NCT04792489 2025-04-24DALY II USA/ MB-CART2019.1 for DLBCLMiltenyi Biomedicine GmbHPhase 2 Recruiting248 enrolled
NCT04029688 2024-12-20A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in Treatment of Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias or Solid TumorsHoffmann-La RochePhase 1/2 Terminated38 enrolled 34 charts